Physician profile
Robert H Aki
NPI 1639271570
$8,325.08
in general payments reported to CMS, 2019-2025
24 companies · $30.06 in 2025
The $30.06 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,403 · 2020: $866 · 2021: $26.56 · 2025: $30.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,193.17 | 2019-2020 | |
| Allergan, INC. | $1,836.12 | 2019 | |
| Davol INC. | $500.58 | 2019-2020 | |
| Conmed Corporation | $150.00 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $144.58 | 2019 | |
| Covidien LP | $107.00 | 2019 | |
| Genentech USA, INC. | $39.05 | 2019 | |
| Abbvie INC. | $30.06 | 2025 | |
| Csl Behring | $29.18 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $28.47 | 2020 | |
| Tei Biosciences INC | $27.52 | 2019 | |
| Becton, Dickinson and Company | $27.25 | 2019 | |
| Olympus America INC. | $27.09 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $24.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.64 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $20.97 | 2020 | |
| Leica Microsystems INC. | $19.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.58 | 2019 | |
| Blue Earth Diagnostics | $16.50 | 2019 | |
| Procept Biorobotics Corporation | $14.14 | 2021 | |
| Abbott Laboratories | $12.42 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.06 | 2019 | |
| Neotract INC. | $11.27 | 2019 | |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Aki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.